Global Virtual Symposium on Alzheimer’s Disease

We are delighted to announce the Global Virtual Alzheimer’s Disease Symposium 2026, organized by Impact Research Communications, taking place online on Thursday, January 22, 2026. This symposium will provide a valuable platform for neuroscientists, clinicians, caregivers, pharmaceutical experts, and public health professionals to share and discuss the latest advances in basic, clinical, and translational research on Alzheimer’s disease and related dementias.

Alzheimer’s disease (AD) is the most common cause of dementia worldwide, posing a major health, social, and economic burden as global populations age. Despite progress in understanding disease mechanisms, including amyloid-β and tau pathologies, neuroinflammation, and synaptic dysfunction, effective disease-modifying therapies remain limited. Ongoing challenges include early detection, slowing disease progression, and improving patient care and quality of life.

The symposium will explore key aspects of Alzheimer’s research, including genetic and molecular mechanisms, biomarkers, neuroimaging advances, cognitive decline, and novel therapeutic approaches. We will also highlight the latest developments in clinical trials, lifestyle and non-pharmacological interventions, and caregiving strategies for patients and families.

By bringing together leading scientists and early-career researchers, this event aims to foster collaborations that advance our understanding of Alzheimer’s disease and support global efforts in prevention, early diagnosis, and effective treatment.

Check out our speakers lineup and join us as we explore new perspectives in Alzheimer’s research and foster global collaboration to accelerate scientific discoveries in the field.

We look forward to welcoming you online on Thursday, January 22, 2026.